[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children]
- PMID: 38245868
- PMCID: PMC10945100
- DOI: 10.37201/req/113.2023
[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children]
Abstract
Objective: The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for infection by MRSA compared to those produced by methicillin-susceptible S. aureus (MSSA) and to know the antibiotic sensitivity profile of MRSA and MSSA isolates.
Methods: A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studied using a binary logistic regression model.
Results: 162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In the univariate analysis the need of hospital admission, antibiotic treatment in the last 3 months, the kind of infection and past MRSA infection or colonisation reached statistical significance. However, only the need of hospital admission and antibiotic treatment in the last 3 months maintained statistical significance in the binary logistic regression model. Correct antibiotic treatment was only prescribed in 26.7% of the MRSA infection cases admitted to the hospital.
Conclusions: Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they have received antibiotic treatment in the last 3 months.
Introducción: Los objetivos de este trabajo fueron conocer la prevalencia de infecciones por Staphylococcus aureus resistente a meticilina (SARM) en la población pediátrica de nuestro departamento de salud, describir los factores de riesgo para infección por SARM frente a las producidas por S. aureus sensible a meticilina (SASM) y conocer el perfil de sensibilidad antibiótica de los aislados de SARM y SASM.
Pacientes y métodos: Se realizó un estudio retrospectivo descriptivo y analítico de las infecciones producidas por SARM frente a las producidas por SASM durante los años 2014 al 2018. Se estudiaron las variables predictoras de SARM mediante un modelo de regresión logística binaria.
Resultados: Se identificaron 162 pacientes con infecciones por S. aureus, 15,4% resistentes a meticilina. Los porcentajes mayores de infección por SARM se dieron entre los niños que precisaron ingreso hospitalario (23,4%). En el análisis univariante alcanzaron significación estadística la necesidad de ingreso hospitalario, el antecedente de haber recibido tratamiento antibiótico en los 3 meses previos, el tipo de infección y el antecedente de infección o colonización previa por SARM. En el modelo de regresión logística la necesidad de ingreso hospitalario y el tratamiento antibiótico reciente mantuvieron significación estadística. Solo recibieron tratamiento antibiótico correcto el 26,7% de los niños que ingresaron con infección por SARM.
Conclusiones: Nuestros resultados sugieren la necesidad de revisar las pautas de tratamiento empírico usando fármacos activos frente a SARM en las infecciones de probable origen estafilocócico que ingresen en el hospital en niños sobre todo si han recibido tratamiento antibiótico reciente.
Keywords: Children; Methicillin resistance; Staphylococcus aureus.
©The Author 2024. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Conflict of interest statement
Los autores declaran no tener ningún conflicto de intereses.
Similar articles
-
Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.J Pediatr Orthop B. 2013 Mar;22(2):158-66. doi: 10.1097/BPB.0b013e32835c530a. J Pediatr Orthop B. 2013. PMID: 23249998
-
Differences Between Methicillin-susceptible Versus Methicillin-resistant Staphylococcus aureus Infections in Pediatrics: Multicenter Cohort Study Conducted in Bogotá, Colombia, 2014-2018.Pediatr Infect Dis J. 2022 Jan 1;41(1):12-19. doi: 10.1097/INF.0000000000003349. Pediatr Infect Dis J. 2022. PMID: 34889869 Free PMC article.
-
[A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant Staphylococcus aureus infection].Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):628-634. doi: 10.3760/cma.j.cn112140-20200505-00469. Zhonghua Er Ke Za Zhi. 2020. PMID: 32842382 Chinese.
-
Correlation Between Biofilm Formation and Antibiotic Resistance in MRSA and MSSA Isolated from Clinical Samples in Iran: A Systematic Review and Meta-Analysis.Microb Drug Resist. 2020 Sep;26(9):1071-1080. doi: 10.1089/mdr.2020.0001. Epub 2020 Mar 10. Microb Drug Resist. 2020. PMID: 32159447
-
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus.Front Cell Infect Microbiol. 2020 Mar 17;10:107. doi: 10.3389/fcimb.2020.00107. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32257966 Free PMC article. Review.
References
-
- World Health Organization (2021) Antimicrobial resistance. [Internet] [citado el 18 de abril de 2023]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
-
- den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, et al. . Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S. aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis. 2013;13(5):409-15. 10.1016/S1473-3099(13)70036-7 - DOI - PubMed
-
- Kolozsvári LR, Kónya J, Paget J, Schellevis FG, Sándor J, Sándor GJ, et al. . Patient-related factors, antibiotic prescribing and antimicrobial resistance of the commensal Staphylococcus aureus and Streptococcus pneumoniae in a healthy population-Hungarian results of the APRES study. BMC Infect Dis. 2019;19(1):253 10.1186/s12879-019-3889-3 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous